Some people are sharing a photo of the AstraZeneca COVID-19 vaccine package leaflet, claiming or suggesting that AstraZeneca COVID-19 vaccine secretly contains the mpox virus!
The photo highlights the portion of the vaccine leaflet that says that it contains a “Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike glycoprotein.”
Truth : AstraZeneca COVID-19 vaccine does not contain mpox virus!
This is yet another example of fake news created and propagated by anti-vaccination activists, and here are the reasons why…
Fact #1 : Mpox is caused by an Orthopoxvirus
Let me start by quickly pointing out that the mpox (formerly known as monkeypox) virus is not a chimpanzee adenovirus.
Mpox is caused by the monkeypox virus (MPV, MPXV, or hMPXV) – a double-stranded DNA virus from the Orthopoxvirus genus in the Poxviridae family. It is closely related to the smallpox virus (variola)
The chimpanzee adenovirus is also a double-stranded DNA virus, but it is from the Mastadenovirus genus in the Adenoviridae family. It is similar to the adenoviruses that cause the common flu in human beings.
These two viruses are as different as cats and dogs. Cats and dogs are both mammals, but as you can tell – they are quite different animals!
Fact #2 : Adenovirus used in AstraZeneca vaccine cannot replicate
The AstraZeneca COVID-19 vaccine uses a chimpanzee adenovirus to “teach” some of our cells to produce the SARS-CoV-2 spike proteins to trigger an immune response.
The chimpanzee adenovirus used in the vaccine – ChAdOx1 – had already been modified from the original ChAd virus serotype Y25 to prevent replication. Therefore, the virus cannot replicate, and is incapable of producing any disease in human beings.
Fact #5 : DRC has very low COVID-19 vaccination rate
It is ludicrous to claim or suggest that the current mpox outbreak is caused by the AstraZeneca COVID-19 vaccine, because it started in the Democratic Republic of the Congo (DRC), which has very low COVID-19 vaccination rates due to poor healthcare infrastructure, political instability and… misinformation!
According to the latest available data, only about 2.6 million people – out of 110 million people, have been vaccinated against COVID-19. That’s a vaccination rate of less than 2.5%, even if you assume they were all “fully-vaccinated”.
Fact #6 : 2022, 2024 monkeypox outbreaks started years later
The AstraZeneca COVID-19 vaccine has been given to over 2.4 billion people globally, since its approval in December 2020. If the AstraZeneca COVID-19 vaccine can actually cause mpox infections, it would have resulted in massive mpox outbreaks all over the world within days of being administered.
Yet the 2022 and 2024 monkeypox outbreaks only started 1.5 to 2.5 years after the AstraZeneca vaccine was introduced. In other words – even the temporal timeline for this ridiculous claim is out of whack!
Please help us FIGHT FAKE NEWS by sharing this fact check article out, and please SUPPORT our work!
Please Support My Work!
Support my work through a bank transfer / PayPal / credit card!
Name : Adrian Wong Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp
Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.
He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.
Can the AstraZeneca COVID-19 vaccine give you monkeypox? Take a look at the viral claims, and find out what the facts really are!
Updated @ 2024-08-20 : Updated, and refreshed after the same claims went viral with the 2024 mpox outbreak Originally posted @ 2022-09-04
Claim : AstraZeneca COVID-19 vaccine can give you monkeypox!
In recent weeks, people have sharing photos of the AstraZeneca COVID-19 vaccine leaflet, claiming that it is evidence that the AstraZeneca vaccine is responsible for the current monkeypox outbreak.
They are highlighting the portion of the vaccine leaflet that says that it contains a “Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike glycoprotein.”
They believe that it is this virus that causes monkeypox, and that the AstraZeneca vaccine is responsible for spreading monkeypox to vaccinated people.
Here are some of the comments that accompany these viral posts :
Who is surprised that after millions of people have been injected with genetically modified chimp virus, there is now an outbreak of monkeypox?
“The AstraZeneca vaccine uses a chimpanzee adenovirus vaccine vector” Makes you wonder doesn’t it.🤔🤔🤔🤔
More monkey business #AstraZeneca #monkeypox
Truth : AstraZeneca COVID-19 vaccine won’t give you monkeypox!
This is yet another example of fake news created and propagated by anti-vaccination activists, and here are the reasons why…
Fact #1 : Adenovirus used in AstraZeneca vaccine cannot replicate
The AstraZeneca Vaxzevria vaccine, codenamed AZD1222, uses a chimpanzee adenovirus to “teach” some of our cells to produce the SARS-CoV-2 spike proteins to trigger an immune response.
The chimpanzee adenovirus used in the vaccine – ChAdOx1 – had already been modified from the original ChAd virus serotype Y25 to prevent replication. Therefore, the virus cannot replicate, and is incapable of producing any disease in human beings.
Fact #2 : Monkeypox is not caused by chimpanzee adenovirus
Monkeypox is caused by the monkeypox virus, which is completely different from the chimpanzee adenovirus.
The monkeypox virus is a double-stranded DNA virus from the Orthopoxvirus genus in the Poxviridae family. It is closely related to the smallpox virus (variola).
The chimpanzee adenovirus is also a double-stranded DNA virus, but it is from the Mastadenovirus genus in the Adenoviridae family. It is similar to the adenoviruses that cause the common flu in human beings.
These two viruses are as different as cats and dogs. Cats and dogs are both mammals, but as you can tell – they are quite different animals!
Monkeypox was first identified and named in 1958, when it was identified in laboratory monkeys in Copenhagen, Denmark.
However, the name monkeypox is a misnomer, as it is not very common in monkeys. Neither did it originate in monkeys, nor does it spread only through monkeys.
It is known to spread through prairie dogs, dormice, squirrels, and non-human primates. It may possibly also spread through rabbits, rats and mice.
Fact #4 : Chimpanzees are not monkeys
Not that it matters, but you should know that chimpanzees and monkeys are of different species.
Chimpanzees and monkeys are both primates, but their last common ancestor dates back some 30 million years ago.
Monkeys are simians; while chimpanzees are great apes, and are genetically closest to human beings.
Fact #5 : 2022, 2024 monkeypox outbreaks started years later
The AstraZeneca COVID-19 vaccine has been given to over 2.4 billion people globally, since its approval in December 2020. If the AstraZeneca COVID-19 vaccine can actually cause mpox infections, it would have resulted in massive mpox outbreaks all over the world within days of being administered.
Yet the 2022 and 2024 monkeypox outbreaks only started 1.5 to 2.5 years after the AstraZeneca vaccine was introduced. In other words – even the temporal timeline for this ridiculous claim is out of whack!
Fact #6 : Monkeypox started infecting people in 1970
The first human monkeypox infections were reported in 1970. As you can tell – that’s almost 50 years before the COVID-19 pandemic, and 51 years before the AstraZeneca vaccine was introduced.
Fact #7 : Monkeypox cases were increasing before COVID-19
At first, monkeypox infections in humans were relatively few – about 400 cases from 1970 to 1986, and they were mostly limited to Central and Weest Africa.
However, it started becoming more common, with 2000 cases per year reported between 2011 and 2014. There were also several small outbreaks in the US (2003 and 2021), UK (2018 and 2021), and Singapore (2019).
These cases all happened long before the COVID-19 pandemic, and certainly long before AstraZeneca and Oxford developed their Vaxzevria vaccine against COVID-19!
Please help us FIGHT FAKE NEWS by sharing this fact check article out, and please SUPPORT our work!
Don’t forget to protect yourself, and your family, by vaccinating against COVID-19!
Please Support My Work!
Support my work through a bank transfer / PayPal / credit card!
Name : Adrian Wong Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp
Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.
He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.
Was the mRNA vaccines just shown to trigger severe nerve damage, including multiple sclerosis?!
Take a look at the viral claim, and find out what the facts really are!
Claim : mRNA Vaccines Trigger Severe Nerve Damage!
The Children’s Health Defense (CHD) activist group, which is chaired by Robert F. Kennedy Jr., just posted an article suggesting that Brazilian researchers uncovered two cases of serious nerve damage in patients who received mRNA COVID-19 vaccines.
This was what was posted on the CHD page on X (formerly Twitter):
Brazilian researchers have uncovered two cases of serious nerve damage in patients who received mRNA COVID-19 vaccines.
Here is an excerpt from the CHD article (archive). Please feel free to skip to the next section for the facts!
COVID vaccine triggers nerve damage, MS
Multiple Sclerosis and Optic Neuritis triggered by COVID-19 mRNA; Neuroimmunology Reports, Jan. 1, 2024.
Brazilian researchers have uncovered two cases of serious nerve damage in patients who received messenger RNA (mRNA) COVID-19 vaccines.
The first case involved a 25-year-old woman presenting weakness on her right side plus lower limb pain, sensory impairment, difficulty walking and bladder trouble one week after the shot. These symptoms, plus imaging tests, led to a diagnosis of multiple sclerosis (MS).
The patient was hospitalized, treated with steroids and released with a prescription for dimethyl fumarate, an MS drug. No mention was made of her current status.
The second case was an 8-year-old boy who, 12 days after his vaccination, developed blurred vision in both eyes. Examination revealed optic disk swelling and brain magnetic resonance imaging revealed three brain lesions.
Symptoms completely resolved after five days of steroid treatment.
The authors of the case studies concluded: “Diseases or symptoms triggered or linked to this new vaccine technology must be reported and studied.”
Let’s take a closer look at the various claims in the article, and find out what the facts really are!
Fact #1 : It Was A Case Presentation
Let me start by pointing out that the Brazilian paper in question was a case presentation submitted to Neuroimmunology Reports, called Multiple Sclerosis and Optic Neuritis triggered by COVID-19 mRNA by Moretti, Fabiani, et. al.
Fact #2 : Paper Did Not Conclude mRNA Vaccines Cause Nerve Damage
If you read the conclusion, you will note that the authors never actually concluded that mRNA vaccines causes nerve damage. The authors only pointed out that such cases should be reported, and that “more studies are still needed”. Here is the relevant quote from the paper, with my emphasis underlined.
Diseases or symptoms triggered or linked to this new vaccine technology must be reported and studied, contributing to worldwide databases.
More studies are still needed on the association between neurological complications and the vaccine against COVID-19. Long-term monitoring is needed if the vaccine can cause or trigger neurological disorders.
Fact #3 : Paper Says Vaccine Benefits Outweigh The Risks
Anyone who reads the conclusion will also realise that the authors actually pointed out that the benefits of vaccinating against COVID-19 outweigh the risks. On top of that, they said that no neurological condition is an absolute contraindication for vaccinating against COVID-19.
Overall, the benefits of vaccination outweigh the risks of neurological complications, and, to date, no neurological condition is an absolute contraindication for vaccination against COVID-19.
Fact #4 : AstraZeneca Vaccine Is A Virus Vector Vaccine
With all due respect to the authors, the editors and the peer-reviewers, I should point out that the first case report does not involve any mRNA vaccine.
The first case involved the Oxford-AstraZeneca COVID-19 vaccine, which is a virus vector vaccine. It is not an mRNA vaccine.
ChAdOx1 was not the vaccine’s name either. Rather, ChAdOx1 was the name of the modified chimpanzee adenovirus the Oxford-AstraZeneca used as its vector.
Fact #5 : First Patient Already Had Multiple Sclerosis
What may not be obvious, but was mentioned in the paper, was that the first patient – who received the AstraZeneca vaccine, already had multiple sclerosis (MS).
The authors pointed out that she already met the 2017 McDonald’s criteria for multiple sclerosis. That meant that this patient had prior MRI-detected lesions, or oligoclonal bans in the spinal fluid, or prior clinical symptoms of MS.
This is because a key requirement for the diagnosis of MS is Dissemination In Time (DIT) – there must be evidence of damage, at different times, and to different parts, of the central nervous system (source).
In fact, the authors pointed out that the COVID-19 vaccination only triggered the symptoms, but did not actually cause multiple sclerosis. Here’s the relevant quote, with my emphasis underlined.
The female patient met the McDonald’s (2017) criteria for multiple sclerosis, and the vaccine only triggered the symptoms.
I should point out that multiple sclerosis patients often suffer such relapses of symptoms that are triggered by anything from viral infections to stress. Certain vaccinations involving live viruses or bacteria can also trigger a relapse.
Since the AstraZeneca COVID-19 vaccine (Vaxzevria) uses a modified chimpanzee virus, it is plausible that it may trigger symptoms in multiple sclerosis patients.
Fact #6 : Multiple Sclerosis Can Cause Optic Neuritis
The second patient in the Brazilian case presentation developed optic neuritis – inflammation of the optic nerve. Optic neuritis is most commonly seen in multiple sclerosis patients.
Even though this 8 year-old boy is not known to have multiple sclerosis, the authors noted that a brain MRI showed three small acute hypertension lesions in his brain. Such brain lesions developing in multiple places over time (Dissemination in Time, DIT) are highly suggestive of multiple sclerosis, as per the McDonald criteria.
In other words – it is possible that this patient may also have multiple sclerosis that may not have been previously diagnosed, whose symptoms was triggered by the vaccine – just like in the first case.
Fact #7 : COVID-19 Infection Can Cause Optic Neuritis
I should also point out that past COVID-19 infections can cause optic neuritis. In fact, this January 2022 case study published in the Indian Journal of Ophthalmology detailed three patients who developed optic neuritis weeks or months after recovering from mild COVID-19 infections.
The authors noted that in those three patients, demyelinating lesions were identified in two cases, while the third case was found with serum anti-myelin antibodies.
Patient 1 suddenly lost vision in his left eye two weeks after recovering from mild COVID-19.
Patient 2 lost vision in his left eye six months after recovering from mild COVID-19.
Patient 3 lost vision in his left eye twice, two weeks after recovering from mild COVID-19, and then again four weeks later.
All three patients recovered their vision, but as you can see – COVID-19 infections can potentially cause optic neuritis long after recovery. It is plausible that the second patient in the Brazilian case presentation may have had a prior COVID-19 infection (before his vaccination).
That is why we cannot draw conclusions from any of these case reports / presentations. They all need to be investigated to determine their actual cause.
It is also important to note that neither patients mentioned in this Brazilian case presentation died.
The first patient recovered partially after treatment with methylprednisolone, and was discharged with the treatment of dimethyl fumarate.
The second patient was also treated with methylprednisolone, and experienced a complete recovery, with no further treatment.
Methylprednisolone is often used in symptomatic attacks of multiple sclerosis. Dimethyl fumarate is also a treatment of multiple sclerosis.
Please help us FIGHT FAKE NEWS by sharing this fact check article out, and please SUPPORT our work!
Don’t forget to protect yourself, and your family, by vaccinating against COVID-19!
Please Support My Work!
Support my work through a bank transfer / PayPal / credit card!
Name : Adrian Wong Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp
Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.
He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.
Guangzhou appears to have reinstated the Health Code, requiring patients and their caregivers to test negative for COVID-19 before being admitted to a hospital!
Guangzhou Patients Must Be COVID Negative For Admission?!
The city of Guangzhou has apparently reinstated the Chinese COVID-19 Health Code requirements from 2 December 2023 onwards.
In a video translated and posted by Jennifer Zeng (archive), the Deputy Director and Spokesperson for the Guangzhou Health Commission Zhang Yi appears to announce an immediate requirement for patients and their caregivers to present a Green Health Code, in order to enter all types of medical institutions.
Effective immediately, patients visiting all levels and types of medical institutions in Guangzhou City and its districts must present a green health code for entry. Dec 2, Guangzhou, Guangdong.
Zhang Yi : From now on, all levels & types of medical institutions in Guangzhou City & its districts for outpatient and emergency department visits will require a green health code for entry.
Bizarrely, patients and their caregivers are expected to undertake PCR nuclei tests for COVID-19, and show a negative test result within the past 24 hours to gain admission!
Zhang Yi : Newly admitted inpatients and their accompanying personnel must present a negative nucleic acid test result from within the past 24 hours for admission.
Less controversially, she called on fever clinics to operate at their maximum capacity, and conduct nucleic acid (PCR) tests on patients.
Zhang Yi : Fever clinics should operate to their fullest capacity. The role of the previously established 114 standardised fever clinics should be fully utilised.
Strengthen the staffing of medical personnel in fever clinics, optimise the waiting area settings and consultation process.
Conduct nucleic acid testing for visiting patients, and implement graded & categorised diagnosis and treatment.
Not Only Guangzhou Patients Must Be COVID Negative For Admission?
China has been experiencing a surge of respiratory illnesses that have alarmed many people, especially when it appeared to cause pneumonia in many children.
The WHO called on China to provide more information, after health monitoring groups like the Program for Monitoring Emerging Diseases (ProMED) reported clusters of undiagnosed pneumonia in children in north China.
China responded within 24 hours, stating that it has not detected any new or usual pathogens causing this surge of respiratory illness, with clusters of pneumonia being blamed on a bacteria – Mycoplasma pneumoniae which has been circulating since May, as well as influenza, respiratory syncytial virus (RSV) and adenovirus that have been circulating since October.
While the negative COVID-19 test looks really bizarre, it is possible that the Chinese government has instituted this requirement to prevent these patients, who are already suffering from pneumonia, from being infected with COVID-19 as well.
Even so, Jennifer Zeng reported (archive) that the Chinese Health Code requirement is not just being reactivated in Guangzhou, but for the entire Guangdong province, as well as the Beijing, Sichuan, Fujian, Shaanxi, and Zhejiang provinces!
The health code is a mobile app used by the CCP during the three-year COVID pandemic to control people’s movements. If your health code turns red or yellow, you can’t go anywhere.
But it’s not just Guangzhou. From what we know so far, Beijing, Sichuan, Fujian, Guangdong, Shaanxi, and Zhejiang Province are also implementing it.
So it is possible that the Chinese government at least suspects that some of these cases of respiratory illnesses may be due to a surge in COVID-19 cases.
To be clear – this reimplementation of the Chinese Health Code appears to be limited to patients attempting to seek medical assistance in clinics and hospitals. It does not appear that the Health Code is being reimplemented to restrict other types of movement in China.
However, reports of a surge in respiratory illnesses, and this (partial) reimplementation of the Health Code requirement will likely put a damper on the revival of the Chinese tourism industry. The Chinese government recently implemented visa-free travel for 6 new countries in an effort to boost tourism.
Please Support My Work!
Support my work through a bank transfer / PayPal / credit card!
Name : Adrian Wong Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp
Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.
He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.
COVID-19 Vaccination In Malaysia : Check The Dose!
There have been a few cases where vaccine recipients have been given less than the recommended dose of a COVID-19 vaccine.
In other cases, it is likely that the vaccine recipients misread the volume of LDV syringes, which are different from regular syringes.
To avoid such misunderstandings, healthcare workers are now asked to show the vaccine recipient the pre-filled syringes before vaccination, and the empty syringe after vaccination.
LDV syringes though, have a special long rubber plunger – the black part. Most people misread it by looking at the tip of this long plunger.
It should be read from the first ring of the LDV plunger, as the picture below shows.
Due to bad publicity and viral fake news on social media, the government took the AstraZeneca vaccine off the mainstream vaccination programme.
It was made available at special vaccination centres, to anyone aged 18 or older who wishes to accept it voluntarily.
Both the AstraZeneca 1.0 and AstraZeneca 2.0 programmes proved to be so popular, the government decided to reintroduce the vaccine to the main vaccination programme.
The government also announced that the second dose of the AstraZeneca vaccine will be set at 12 weeks, instead of 4 weeks.
However, you can ask for an earlier second dose, if you need to travel for work or study.
Malaysia COVID-19 Vaccine Injury Fund : Up To RM500K!
Officially called Bantuan Khas Kewangan Kesan Mudarat Vakin COVID-19 (Special Financial Assistance for COVID-19 Vaccine Adverse Effects), this COVID-19 vaccine injury fund will pay out :
RM 50,000 for serious side effects that requires extended hospitalisation
RM 500,000 for permanent disability or death from the COVID-19 vaccine
It will receive an initial funding of RM 10 million (US$2.5 million) under the National Disaster Relief Trust Fund.
The vaccines are currently administered at 600 locations across the country, that consist of :
Ministry of Health healthcare facilities
Ministry of Defence facilities
University hospitals
On 29 March 2021, Malaysia announced that the free COVID-19 vaccines will also be available at private clinics and hospitals starting 19 April 2021.
As of 12 April 2021, over 2300 private clinics have registered to take part in the vaccination programme. The 203 private hospitals in Malaysia could follow suit.
The Malaysia COVID-19 vaccine program will kick off on 24 February 2021, with the arrival of the Pfizer-BioNTech BNT162b2 vaccine, and last until February 2022.
Phase 1 : 24 February – April 2021
Phase 1 will involve immunising 500,000 front line workers, divided into two groups :
Group 1 : public and private healthcare workers
Group 2 : frontliners providing essential services and national defence (like teachers, the police, civil defence (RELA), firefighters, rescue workers, and the armed forces).
* Originally scheduled to start in first week of March, it was brought forward to 24 February 2021.
Phase 2 will focus on immunising 9.4 million high-risk adults, divided into two groups :
Group 1 : remaining healthcare workers and frontliners (including defence)
Group 2 : senior citizens 60 years or older, disabled adults, and vulnerable adults with chronic diseases, like heart disease, obesity, diabetes and hypertension
This phase kicks off on 19 April 2021, with eligible recipients being notified as early as 5 April 2021.
Phase 3 : May 2021 – February 2022
Phase 3 will make the COVID-19 vaccine available to the rest of the population :
adults 18 years or older
– prioritised from red zones > yellow zones > green zones
This may be the last phase, but it is the most critical phase to build herd immunity that will protect the rest of the population that cannot be vaccinated against COVID-19.
Malaysia COVID-19 Vaccine : FREE For ALL Citizens + Foreign Residents
The COVID-19 vaccines will be provided FREE for all Malaysian citizens, as well as foreign residents.
Pfizer COVID-19 Vaccine Plan For Malaysia : Both Doses Reserved
On 13 February 2021, Dr. Kalaiarasu Periasamy, the Director of the Institute of Clinical Research (ICR) announced the Malaysia Ministry of Health’s “One Dose Injected, One Dose Reserved” strategy.
Two doses will be reserved for each person, with the second dose administered 21 days after the first dose, as recommended by Pfizer and BioNTech.
The second dose for the Sinovac vaccine will be administered 14 days after the first dose.
The second dose for the AstraZeneca vaccine will be administered 12 weeks after the first dose.
When you arrive to a vaccination centre, you will be registered for both doses. You will be given a vaccination card, and registered in the MySejahtera app as well.
Malaysia COVID-19 Vaccine Plan : Path To 80% Coverage
Malaysia originally aimed to achieve vaccination coverage of 82.8% of the adult population, approximately 26.5 million people.
But in their 5 February 2021 update, the Ministry of Health now aim to immunise 25.6 million people – 80% of the adult population, or about 76.6% of the population.
If they succeed, this would put Malaysia somewhere between the minimum 70% and the ideal 80% immunisation targets that many scientists believe are necessary to achieve herd immunity against COVID-19.
Path To 80% COVID-19 Vaccination Coverage
This is what the COVID-19 vaccine supply will be like for the adult population in Malaysia :
46.4% will receive the COMIRNATY vaccine from Pfizer-BioNTech
34.9% will receive the CoronaVac vaccine from Sinovac Biotech
9.3% will receive the AZD1222 vaccine from AstraZeneca-Oxford
9.3% will receive the Sputnik V vaccine from Gamaleya Research Institute.
Why So Many Vaccines?
According to KKM, they decided to purchase from different vaccine manufacturers to ensure a sufficient supply of vaccines.
We had earlier pointed out that it was impossible for any one, or two, or even three vaccine manufacturer to manufacture enough vaccines to vaccinate the entire world.
It only makes sense that Malaysia will need to purchase from multiple companies to receive enough doses to vaccinate its population.
The only problem with using six different vaccines? Healthcare workers and logistics will need to keep track and deal with different administration and storage requirements.
While it may be possible to avoid that by allocating different vaccines by location, it would make for poor optics and possibly poorer uptake of the vaccination program.
COVID-19 : How To Keep Safe!
Here are a few simple steps to stay safe from the SARS-CoV-2 virus :
Avoid suspected cases or disease hotspots, like hospitals, if possible!
2021-06-04 : Vaccine underdose, LDV syringe reading, vaccine dependent registration and removal, AstraZeneca vaccine, painkillers, many other changes
2021-04-28 : Vaccination process, joint vaccinations, AstraZeneca vaccine, other changes
2021-04-14 : Phase 2 vaccination updates, side effect reporting, vaccination appointments, private clinics + hospitals
2021-04-06 : Details of CanSino Convidecia vaccine. Manual registration at private and public clinics. 2021-03-30 : Phase 2 details, free + paid vaccines at private clinics and hospitals.
2021-03-25 : New vaccine purchases, vaccine injury fund, domestic helper registration.
2021-03-18 : My COVID-19 Vaccination Badge, dependent registration.
2021-02-12 : 5 ways to sign up for COVID-19 vaccination programme
2021-02-05 : KKM’s plan to immunise 25.6 million people in Malaysia.
2021-01-28 : CoronaVac and Sputnik V vaccine purchase.
2021-01-12 : Added the additional purchase of the Pfizer vaccine.
Originally posted @ 2020-12-31
If you like our work, you can help support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Any help you can render is greatly appreciated!
Malaysia just announced the purchase of 6.4 million doses of the Oxford-AstraZeneca COVID-19 vaccine, and is in final negotiations with three other vaccine companies!
Malaysia Buys 6.4 Million AstraZeneca COVID-19 Vaccine Doses!
On 22 December 2020, Malaysia announced the purchase of 6.4 million doses of the Oxford-AstraZeneca COVID-19 vaccine.
The purchase was signed earlier on Monday, 21 December 2020, but the deal only announced today.
Because the AstraZeneca COVID-19 vaccine requires two doses per person, the 6.4 million doses are only enough to vaccinate a maximum of 3.2 million people – approximately 10% of the Malaysian population.
Together with 12.8 million doses of the Pfizer-BioNTech COVID-19 vaccine, Malaysia now has enough to vaccinate 30% of the population by the end of 2021. The total costs of both purchases are about US$504.4 million.
That is, however, nowhere close enough to create herd immunity, which requires 70%-80% of the population to be vaccinated.
After AstraZeneca Vaccine Deal : Sinovac, Can-Sino, Gamaleya Vaccines
Malaysia plans to vaccinate some 83% of the population. To achieve that goal, the Malaysian government announce that they are in final negotiations with :
two Chinese companies – Sinovac and Can-Sino Biologics,
as well as Russian company Gamaleya Institute.
COVID-19 : How To Keep Safe!
Here are a few simple steps to stay safe :
Avoid suspected cases or disease hotspots, like hospitals, if possible!
If you like our work, you can help support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Any help you can render is greatly appreciated!
